Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00007852
Status:
COMPLETED
Last Update Posted:
2023-09-01
First Post:
2001-01-06
Brief Title:
Rituximab Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkins Lymphoma
Sponsor:
University of Nebraska
Organization:
University of Nebraska
Organization Data
Organization:
University of Nebraska
Class:
OTHER
Study ID:
0045-00-FB
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Nebraska
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |
| National Cancer Institute NCI | NIH |